SciBac careers

SciBac, creates rEvolutionary live biotherapeutics that treat antibiotic resistant disease while fortifying the microbiome. They use a patented platform technology to improve the efficacy and survival of safe, probiotic strains to target superbugs and fight fire with fire. Their two products in drug development have been shown in pre-clinical trialsesting to have strong therapeutic potential. The first uses multiple mechanisms to target the unmet needs for treating chronic lung infections in Cystic Fibrosis, including: eliminating the formation of mucus, cutting through biofilm, reducing inflammation, and directly killing Staph (including MRSA) and Pseudomonas.